Childhood rhabdomyosarcoma
Childhood Rhabdomyosarcoma is a rare type of cancer that primarily affects children. It is a soft tissue sarcoma, which means it originates in the soft tissues of the body, such as the muscles, tendons, and connective tissues. The most common sites for childhood rhabdomyosarcoma are the head and neck, the urinary and reproductive organs, and the arms or legs.
Etiology[edit | edit source]
The exact cause of childhood rhabdomyosarcoma is unknown. However, certain genetic conditions, such as Li-Fraumeni syndrome and Neurofibromatosis type 1, are known to increase the risk of developing this disease.
Symptoms[edit | edit source]
The symptoms of childhood rhabdomyosarcoma vary depending on the location of the tumor. Common symptoms include a lump or swelling that continues to grow, pain or soreness, difficulty urinating or having bowel movements, and bleeding from the nose, throat, vagina, or rectum.
Diagnosis[edit | edit source]
Diagnosis of childhood rhabdomyosarcoma typically involves a physical examination, medical history, and various tests such as blood tests, imaging tests, and a biopsy. The biopsy involves removing a small sample of tissue from the tumor to be examined under a microscope.
Treatment[edit | edit source]
Treatment for childhood rhabdomyosarcoma typically involves a combination of surgery, chemotherapy, and radiation therapy. The specific treatment plan will depend on several factors, including the size and location of the tumor, the child's overall health, and whether the cancer has spread to other parts of the body.
Prognosis[edit | edit source]
The prognosis for children with rhabdomyosarcoma varies widely and depends on many factors, including the type and stage of the cancer, the child's age and overall health, and how well the cancer responds to treatment.
See also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD